Cardiff Oncology Inc. (CRDF)
NASDAQ: CRDF
· Real-Time Price · USD
3.88
0.26 (7.18%)
At close: Jun 06, 2025, 3:59 PM
3.95
1.80%
After-hours: Jun 06, 2025, 05:59 PM EDT
7.18% (1D)
| Bid | 3.8 |
| Market Cap | 258.12M |
| Revenue (ttm) | 479K |
| Net Income (ttm) | -48.86M |
| EPS (ttm) | -0.93 |
| PE Ratio (ttm) | -4.17 |
| Forward PE | -3.73 |
| Analyst | Buy |
| Ask | 3.96 |
| Volume | 1,105,332 |
| Avg. Volume (20D) | 1,138,119 |
| Open | 3.65 |
| Previous Close | 3.62 |
| Day's Range | 3.63 - 3.93 |
| 52-Week Range | 2.01 - 5.64 |
| Beta | 1.56 |
About CRDF
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRDF
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRDF stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
+19.88%
Cardiff Oncology shares are trading higher after P...
Unlock content with
Pro Subscription
6 months ago
+54.92%
Cardiff Oncology shares are trading higher after the company announced the initial data from its CRDF-004 Phase 2 trial evaluating Onvansertib.
